GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PureTech Health PLC (NAS:PRTC) » Definitions » Book Value per Share

PRTC (PureTech Health) Book Value per Share : $13.19 (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is PureTech Health Book Value per Share?

PureTech Health's book value per share for the quarter that ended in Jun. 2024 was $13.19.

During the past 12 months, PureTech Health's average Book Value Per Share Growth Rate was -29.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -8.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 7.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of PureTech Health was 333.60% per year. The lowest was -8.20% per year. And the median was 32.25% per year.

PureTech Health's current price is $22.05. Its book value per share for the quarter that ended in Jun. 2024 was $13.19. Hence, today's PB Ratio of PureTech Health is 1.29.

During the past 12 years, the highest P/B Ratio of PureTech Health was 28.71. The lowest was 0.88. And the median was 1.97.


PureTech Health Book Value per Share Historical Data

The historical data trend for PureTech Health's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PureTech Health Book Value per Share Chart

PureTech Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.41 23.43 20.62 19.47 17.07

PureTech Health Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.30 19.47 18.57 17.07 13.19

Competitive Comparison of PureTech Health's Book Value per Share

For the Biotechnology subindustry, PureTech Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PureTech Health's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PureTech Health's PB Ratio distribution charts can be found below:

* The bar in red indicates where PureTech Health's PB Ratio falls into.



PureTech Health Book Value per Share Calculation

PureTech Health's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(464.07-0.00)/27.19
=17.07

PureTech Health's Book Value Per Share for the quarter that ended in Jun. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(315.87-0.00)/23.94
=13.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


PureTech Health  (NAS:PRTC) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


PureTech Health Book Value per Share Related Terms

Thank you for viewing the detailed overview of PureTech Health's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PureTech Health Business Description

Traded in Other Exchanges
Address
6 Tide Street, Suite 400, Boston, MA, USA, 02210
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.